Energy expenditure and respiratory diseases: Is there a link?

Expert Review of Respiratory Medicine

Volumn 2, Issue 4, 2008, Pages 495-503

  Gregersen, Nikolaj Ture ^a   Chaput, Jean Philippe ^b   Astrup, Arne ^a   Tremblay, Angelo ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Adaptive thermogenesis; Chronic obstructive pulmonary disease; Energy expenditure; Obstructive sleep apnea syndrome; Organochlorine; Oxygen transport system

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY EXPENDITURE; HORMONE ACTION; HORMONE METABOLISM; HUMAN; HYPERMETABOLISM; HYPOXIA; MITOCHONDRIAL ENERGY TRANSFER; MUSCLE ATROPHY; OBESITY; OXYGEN SATURATION; OXYGEN TRANSPORT; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; THERMOGENESIS; WEIGHT REDUCTION;

EID: 55149106531     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2.4.495     Document Type: Review

References (49)

1. Ricquier D. Fundamental mechanisms of thermogenesis. C. R. Biologies 329, 578-586 (2006).
2. Tremblay A, Major G, Doucet E, Trayhurn P, Astrup A. Role of adaptive thermogenesis in unsuccessful weight-loss intervention. Future Lipidol. 2(6), 651-658 (2007).
3. Hins J, Sérès F, Alméras N, Tremblay A. Relationship between severity of nocturnal desaturation and adaptive thermogenesis: preliminary data of apneic patients tested in a whole-body indirect calorimetry chamber. Int. J. Obes. 30(3), 574-577 (2006).
4. Sergi G, Coin A, Marin S et al. Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease. Respir. Med. 100, 1918-1924 (2006).
5. Gambert S, Ricquier D. Mitochondrial thermogenesis and obesity. Curr. Opin. Clin. Nutr. Metab. Care 10(6), 664-670 (2007).
6. Nübel T, Ricquier D. Respiration under control of uncoupling proteins: clinical perspective. Horm. Res. 65, 300-310 (2006).
7. Astrup A, Simonsen L, Bülow J, Madsen J, Christensen NJ. Epinephrine mediates facultative carbohydrate-induced thermogenesis in human skeletal muscle. Am. J. Physiol. 248, E507-E515 (1985).
8. Zhao J, Cannon B, Nedergaard J. α1-adrenergic stimulation potentiates the thermogenic action of β3-adrenoreceptor-generated cAMP in brown fat cells. J. Biol. Chem. 272(56), 32847-32856 (1997).
9. Rousset S, Alves Guerra MC, Mozo J et al. The biology of mitochondrial uncoupling proteins. Diabetes 53 (Suppl. 1), S130-S135 (2004).
10. Simonides WS, Thelen MHM, van der Linden CG, Muller A, van Hardeveld C. Mechanisms of thyroid-hormone regulated expression of the SERCA genes in skeletal muscle: implications for thermogenesis. Biosci. Rep. 21 (2), 139-154 (2001).
11. Silva JE. Thermogenic mechanisms and their hormonal regulation. Physiol. Rev. 86, 435-464 (2006).
12. Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid 12 (6), 447-452 (2002).
13. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344(7), 501-509 (2001).
14. Sprague JE, Yang X, Sommers J, Gilman TL, Mills EM. Roles of norepinephrine, free fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis. J. Pharmacol. Exp. Ther. 320, 274-280 (2007).
15. Pelletier C, Imbeault P, Tremblay A. Energy balance and pollution by organochlorines and polychlorinated biphenyls. Obes. Rev. 4(1), 17-24 (2003).
16. Pelletier C, Doucet E, Imbeault P, Tremblay A. Associations between weight loss-induced changes in plasma organochlorine concentrations, serum T3 concentration, and resting metabolic rate. Toxicol. Sci. 67(1), 46-51 (2002).
17. Imbeault P, Tremblay A, Simoneau JA, Joanisse DR. Weight loss-induced rise in plama pollutant is associated with reduced skeletal muscle oxidative capacity. Am. J. Physiol. Endocrinol. Metab. 282, E574-E579 (2002).
18. Chewier J, Dewailly E, Ayotte P et al. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int. Obes. Relat. Metab. Disord. 24 (10), 1272-1278 (2000).
19. Tremblay A, Pelletier C, Doucet E, Imbeault P. Thermogenesis and weight loss in obese individuals: a primary association with organochlorine pollution. Int. J. Obes. Relat. Metab. Disord. 28(7), 936-939 (2004).
20. Cawthorn WP, Sethi JK. TNF-α and adipocyte biology. FEBS Lett. 582(1), 117-131 (2008).
21. Amaral ME, Barbuio R, Milanski M et al. Tumor necrosis factor-α activates signal transduction in hypothalamus and modulates the expression of proinflammatory proteins and orexigenic/ anorexigenic neurotransmitters. J. Neurochem. 98(1), 203-212 (2006).
22. Beard JL, Borel MJ, Derr J. Impaired thermoregulation and thyroid function in iron-deficiency anemia. Am. J. Clin. Nutr. 52, 813-819 (1990).
23. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 114(1), 104-108 (2004).
24. Kretsch MJ, Fong AKH, Green MW, Johnson HL. Cognitive function, iron status, and hemoglobin concentration in obese dieting women. Eur. J. Clin. Nutr. 52, 512-518 (1998).
25. Antó JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur. Respir. J. 17, 982-994 (2001).
26. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur. Respir. J. 30(5), 993-1013 (2007).
27. Marquis K, Debigaré R, Lacasse Y et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 166, 809-813 (2002).
28. Creutzberg EC, Schols AMWJ, Bothmer-Quaedvlieg FCM, Wouters EFM. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur. J. Clin. Nutr. 52, 396-401 (1998).
29. Schols AMWJ, Fedrix EWHM, Soeters PB, Westerterp KR, Wouters EFM. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 54, 983-987 (1991).
30. Tang NLS, Chung ML, Elia M et al. Total daily energy expenditure in wasted chronic obstructive pulmonary disease patients. Eur. J. Clin. Nutr. 56, 282-287 (2002).
31. Hugli O, Schutz Y, Fitting J-W. The daily energy expenditure in stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 153, 294-300 (1996).
32. Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur. Respir. J. 31(1), 204-212 (2008).
33. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur. Respir. J. 22(Suppl. 46), S76-S80 (2003).
34. Takabatake N, Nakamura H, Abe S et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 161(4), 1179-1184 (2000).
35. Pitsiou G, Kyriazis G, Hatzizisi O, Argyropoulou P, Mavrofridis E, Patakas D. Tumor necrosis factor-α serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir. Med. 96(8), 594-598 (2002).
36. Banno K, Kryger MH. Sleep apnea: clinical investigations in humans. Sleep Med. 8(4), 400-426 (2007).
37. Phillips BG, Hisel TM, Kato M et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J. Hypertens. 17(9), 1297-1300 (1999).
38. Eckert DJ, Malhotra A. Pathophysiology of adult obstructive sleep apnea. Proc. Am. Thorac. Soc. 5(2), 144-153 (2008).
39. Stenlöf K, Grunstein R, Hedner J, Sjöström L. Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am. J. Physiol. 271 (34), E1036-E1043 (1996).
40. Major GC, Sériès F, Tremblay A. Does the energy expenditure status in obstructive sleep apnea favour a positive energy balance? Clin. Invest. Med. 30(6), E101-E107(2007).
41. Hong S, Dimsdale JE. Physical activity and perception of energy and fatigue in obstructive sleep apnea. Med. Sci. Sports Exerc. 35(7), 1088-1092 (2003).
42. Lin CC, Chang KC, Lee KS. Effects of treatment by laser-assisted uvuloplasty on sleep energy expenditure in obstructive sleep apnea patients. Metabolism 51 (5), 622-627 (2002).
43. Sawhney RC, Malhotra AS, Thyroid function during intermittent exposure to hypobatic hypoxia. Int. J. Biometeorol. 34(3), 161-163 (1990).
44. Ciftci TU, Kokturk O, Burkan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28(2), 87-91 (2004).
45. Minoguchi K, Tazaki T, Yokoe T et al. Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome. Chest 126(5), 1473-1479 (2004).
46. Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol. Scand. 177(3), 385-390 (2003).
47. Blaak EE, van Baak MA, Kempen KP, Saris WH. Role of α- and β-adrenoceptors in sympathetically mediated thermogenesis. Am. J. Physiol. 264(1), E11-E17 (1993).
48. 2-adrenergic receptor characteristics in sleep apnea patients. Sleep 18(1), 39-42 (1995).
49. Major GC, Doucet E, Trayhurn P, Astrup A, Tremblay A. Clinical significance of adaptive thermogenesis. Int. J. Obes. 31(2), 204-212 (2007).